A Case Report of Anaphylactic Shock During Caesarean Section under Spinal Anesthesia

Authors
1 Department of Anesthesiology, Allied Medical Sciences Faculty, Kashan University of Medical Sciences, Kashan, Iran
2 Department of Gynecology, Neyshabur University of Medical Sciences, Neyshabur, Iran
3 Department of Anesthesia, Neyshabur University of Medical Sciences, Neyshabur, Iran
4 Department of Anesthesia, Hakim Hospital, Neyshabur University of Medical Sciences, Neyshabur, Iran
5 Department of Internal Medicine and Nephrology, Neyshabur University of Medical Sciences, Neyshabur, Iran
Abstract
Introduction

Anaphylaxis is an acute multi-organ dysfunction syndrome produced by the immunogenic release of inflammatory mediators from mast cells and basophils. This complication is typically a result of medications or substances used during surgery and can have fatal consequences.

Case

A 41-year-old woman underwent spinal anesthesia for cesarean section. After the delivery of the fetus and clamping of the umbilical cord, 5 units of oxytocin were injected intravenously and 25 units were

infused. All infusions were stopped when the patient complained of swollen lips, periorbital edema, and skin rashes. Subsequently, the patient experienced agitation, decreased SPO2, respiratory distress, and loss of peripheral pulses and was subjected to tracheal intubation. Subsequently, the patient developed ventricular tachycardia, and immediate cardiopulmonary resuscitation was initiated. The patient was cared for until the improvement of respiratory and hemodynamic status. After extubation, the patient was transferred to the intensive care unit and discharged after 24 days of treatment with improved condition.

Conclusion

Anaphylaxis is a life-threatening reaction in a pregnant mother, but its complications in the mother and neonate can be prevented through interdisciplinary cooperation, rapid diagnosis, and treatment.
Keywords

1. Marino PL. The ICU book. 4th ed. Philadelphia, Lippincott: williams & wilkins; 2007, 397-401
2. Dewachter P, Mouton-Faivre C, Emala CW, Riou B. Anaphylaxis and anesthesia: controversies and new insights. Anesthesiology. 2009;111(5):1141-50.
3. Bruhns P, Chollet-Martin S. Mechanisms of human drug-induced anaphylaxis. J. Allergy Clin. Immunol. 2021;147(4):1133-42.
4. Cardona V, Ansotegui IJ, Ebisawa M, El-Gamal Y, Rivas MF, Fineman S, et al. World allergy organization anaphylaxis guidance 2020. WAOjournal. 2020;13(10):100472.
5. Simionescu AA, Danciu BM, Stanescu AMA. Severe anaphylaxis in pregnancy: a systematic review of clinical presentation to determine outcomes. J. Pers. Med. 2021;11(11):1060.
6. McCall SJ, Bunch KJ, Brocklehurst P, D'Arcy R, Hinshaw K, Kurinczuk JJ, et al. The incidence, characteristics, management and outcomes of anaphylaxis in pregnancy: a population‐based descriptive study. BJOG. 2018;125(8):965-71.
7. Chaudhuri K, Gonzales J, Jesurun C, Ambat M, Mandal-Chaudhuri S. Anaphylactic shock in pregnancy: a case study and review of the literature. Int. J. Obstet. Anesth. 2008;17(4):350-7.
8. Fisher M, Baldo B, editors. The incidence and clinical features of anaphylactic reactions during anaesthesia in Australia. Ann Fr Anesth Réanim; 1993: Elsevier.
9. Gouel-Chéron A, Harpan A, Mertes P-M, Longrois D. Management of anaphylactic shock in the operating room. La Presse Médicale. 2016;45(9):774-83.
10. Dewachter P, Jouan-Hureaux V, Franck P, Menu P, de Talancé N, Zannad F, et al. Anaphylactic shock: a form of distributive shock without inhibition of oxygen consumption. Anesthesiology. 2005;103(1):40-9.
11. Harper N, Cook T, Garcez T, Farmer L, Floss K, Marinho S, et al. Anaesthesia, surgery, and life-threatening allergic reactions: epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit Project (NAP6). Br. J. Anaesth. 2018;121(1):159-71.
12. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet. 1977;309(8009):466-9.
13. Mertes PM, Malinovsky JM, Mouton-Faivre C, Bonnet-Boyer MC, Benhaijoub A, Lavaud F, et al. Anaphylaxis to dyes during the perioperative period: reports of 14 clinical cases. J. Allergy Clin. 2008;122(2):348-52.
14. keith PK DJ, Kruszewski J, Jankowski M. McMaster Textbook of Internal Medicine2022.
15. Reitter M, Petitpain N, Latarche C, Cottin J, Massy N, Demoly P, et al. Fatal anaphylaxis with neuromuscular blocking agents: a risk factor and management analysis. Allergy. 2014;69(7):954-9.
16. Garvey L, Mertes P. Perioperative anaphylaxis—management and outcomes in NAP6. Br. J. Anaesth. 2018;121(1):120-3.
17. Muraro A, Worm M, Alviani C, Cardona V, DunnGalvin A, Garvey LH, et al. EAACI guidelines: anaphylaxis (2021 update). Allergy. 2022;77(2):357-77.
18. Simionescu AA, Danciu BM, Stanescu AMA. Severe Anaphylaxis in Pregnancy: A Systematic Review of Clinical Presentation to Determine Outcomes. J Pers Med. 2021;11(11).
19. Vijayan V, Gunasekaran A, Vk M. Anaesthetic management of a parturient presenting with suspected oxytocin allergy. Indian J. Anaesth. 2022;66(9).Chen G, Wang Z, Wang D, Qiu C, Liu M, Chen X, et al.